Nov 19, 2025 at 9:16 AM#41
Saving this for reference. Top-tier content.
Last edited: Nov 19, 2025 at 10:16 AM
14 17SleepFixSam, PurityPaulOR, MaxMetOK and 11 others
Reply Quote Save Share Report
Nov 19, 2025 at 9:33 AM#42
Slightly tangential to Novo Nordisk CagriSema but Dr.EM_Chicago reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Last edited: Nov 19, 2025 at 1:33 PM
50 2sarah_TO, wendy_avl, jason_paloalto and 47 others
Reply Quote Save Share Report
Nov 19, 2025 at 10:07 AM#44
Want to share my personal experience related to Novo Nordisk CagriSema Phase 3 since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 287 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 12 months later: I am down 47 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Novo Nordisk aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
Last edited: Nov 19, 2025 at 12:07 PM
20 0B12Beth, RickReta_CO, PharmHunterJen and 17 others
Reply Quote Save Share Report
Nov 19, 2025 at 10:24 AM#45
Relevant to Novo Nordisk CagriSema Phase 3 — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 233 → 103 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Last edited: Nov 19, 2025 at 11:24 AM
30 20KristenIndy, MarkLI_maint, Dr.PeteFamMed and 27 others
Reply Quote Save Share Report